Evolution In Prostate Cancer Diagnostics Creates New Opportunities For Medtech
Fuld + Company
In the US, prostate cancer remains a challenge for men’s health, with approximately 174,650 new cases expected in 2019, third […]
Syed Shehab, MD is a Health + Life Science Analyst at Fuld + Company. After a stint in Internal Medicine at the Boston Medical Center, Syed decided to join the consulting world. In addition to attending the Larner College of Medicine, at the University of Vermont, he graduated from Vassar College with a major in Biochemistry and a minor in Physics. His interests are in healthcare reform, value-based care and population health. He likes to read narrative non-fiction and is a contributing writer for various medical blogs.